Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6 books (10 items)

1.
Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease.

Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease.

National Clinical Guideline Centre (UK).

London: National Institute for Health and Care Excellence (UK); 2014 Jul. (NICE Clinical Guidelines, No. 181.)

2.
Diet and Health: Implications for Reducing Chronic Disease Risk.

Diet and Health: Implications for Reducing Chronic Disease Risk.

National Research Council (US) Committee on Diet and Health.

Washington (DC): National Academies Press (US); 1989.

3.
Detection of Associations Between Trial Quality and Effect Sizes [Internet].

Detection of Associations Between Trial Quality and Effect Sizes [Internet].

Hempel S, Miles J, Suttorp MJ, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Jan.

4.
Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease.

Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease.

Institute of Medicine (US) Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease; Micheel CM, Ball JR, editors.

Washington (DC): National Academies Press (US); 2010.

5.
6.
Some Pharmaceutical Drugs.

Some Pharmaceutical Drugs.

IARC Working Group on the Evaluation of Carcinogenic Risk to Humans.

Lyon (FR): International Agency for Research on Cancer; 1996. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 66.)

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center